Divis Laboratories’ Unit-II at Visakhapatnam, Andhra Pradesh has had an inspection by the US Food and Drug Administration (USFDA) from November 29, 2016 to December 06, 2016. The company has been issued a form 483 with 5 observations and these shall be responded within the time permitted.
Earlier, the company had successful inspection by the USFDA for its Unit-2 at Chippada, Bheemunipatnam near Visakhapatnam during February, 2016 with no observations.
Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1532.85 |
Dr. Reddys Lab | 5812.50 |
Cipla | 1403.90 |
Zydus Lifesciences | 1104.45 |
Lupin | 1661.90 |
View more.. |